Dabigatran use and cerebrovascular event risk across body mass index in atrial fibrillation: a real-world nested case-control study.

Mahawish KM, Feigin V, Barber PA, Bennett DA, Krishnamurthi R, White HD.

Open source

DOI
10.1007/s11239-026-03394-1
Published
2026-09-07
Container
J Thromb Thrombolysis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11239-026-03394-1,
  title = {Dabigatran use and cerebrovascular event risk across body mass index in atrial fibrillation: a real-world nested case-control study.},
  author = {Mahawish KM and  Feigin V and  Barber PA and  Bennett DA and  Krishnamurthi R and  White HD.},
  year = {2026},
  journal = {J Thromb Thrombolysis},
  doi = {10.1007/s11239-026-03394-1},
  url = {https://doi.org/10.1007/s11239-026-03394-1}
}

RIS

TY  - JOUR
TI  - Dabigatran use and cerebrovascular event risk across body mass index in atrial fibrillation: a real-world nested case-control study.
AU  - Mahawish KM
AU  -  Feigin V
AU  -  Barber PA
AU  -  Bennett DA
AU  -  Krishnamurthi R
AU  -  White HD.
PY  - 2026
JO  - J Thromb Thrombolysis
DO  - 10.1007/s11239-026-03394-1
UR  - https://doi.org/10.1007/s11239-026-03394-1
ER  - 

APA

KM, M., V, F., PA, B., DA, B., R, K., & HD., W. (2026). Dabigatran use and cerebrovascular event risk across body mass index in atrial fibrillation: a real-world nested case-control study.. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-026-03394-1

Source records